If you’re following along at all with the TikTok news, you’ll know that the app faced a temporary ban in the US followed by a quick reversal – for now. The platform has become a global smash hit since it lets users post short-form videos with ease, along with seamless app navigation enabling them to instantly view and interact with videos they may be interested in.

A healthcare media agency wanted to increase awareness of their brand with additional direct to consumer (DTC), HIPAA and NAI compliant, privacy safe audiences. They wanted to drive prescriptions for consumers with migraines. The audiences needed to be applicable across channels and activatable on their preferred demand side platform (DSP).

Launching a new pharmaceutical product is a high-stakes endeavor, with nearly 40% of launches failing to meet expectations. To improve these odds, companies must shift to a data-driven approach, leveraging real-world insights to engage decision-makers effectively across the patient journey.

Authored by Lauren Kushner, Head of Healthcare at MiQ, and Ted Sweetser, VP of Advertising Partnerships and Strategy at PurpleLab. 2024 was a year of considerable change for the pharmaceutical industry. The biggest trend was undoubtedly the progression of the Inflation Reduction Act’s negotiated drug pricing, which sees CMS negotiating on pricing for a published…

Learn more about what PurpleLab can do for Clinical Trials Life Sciences Clinical trials are essential for drug development, yet they frequently face delays due to ineffective site selection, leading to protocol violations, compromised data quality, and soaring costs. In fact, 90% of trials fail to meet their timelines, often due to inadequate staffing and…

This article highlights some of the key takeaways of webinar sponsored by Datavant.The webinar included a panel of representatives from leading companies in pharmaceutical marketing and technology, each bringing unique perspectives on marketing trends, data, compliance, activation and strategy: Scott Ronay, Partnerships, Datavant Joe Kotz, SVP Product Sales, VideoAmp Ted Sweetser VP of Advertising, PurpleLab…

The value of real-world data (RWD) and real-world evidence (RWE) for pharmaceutical companies goes far beyond clinical and drug development applications, such as clinical trial feasibility studies, manufacturing, health economic and outcomes research and medical affairs. These datasets are also recognized as critical tools for shaping effective marketing and commercial strategies. The importance of real-world…

More than a year has passed since Humira biosimilars were launched in the US, and with these, several other biosimilar drug approvals that either directly compete with Humira or are indicated for other rare immunologic conditions, macular degeneration, and oncology and hematological disease.  Ongoing industry surveillance of biosimilars and the   Source: “Biosimilars are becoming more widely available,…

The research is clear: Data drives better health outcomes.  Data has the power to transform how healthcare is delivered and guide organizations toward more patient-centered, value-driven care. Even though data is abundant, it’s often siloed or delivered in disparate data sets, and companies commonly lack the necessary resources to turn the data into insights.   Making…